Skip to content
mefloquine

Structure via PubChem · Public domain (PubChem)

EntityQ736270· pop 31· linked from 1,470 articles

mefloquine

Sign in to save

Also known as WR-142490, GNF-Pf-5544, alpha-2-Piperidinyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol, [(R*,S*)-2,8-bis(trifluoromethyl)quinolin-4-yl]-(2-piperidyl)methanol, Ro-215998, Lariam, Mefloquin, Mefloquina

Mefloquine, sold under the brand name Lariam among others, is a medication used to prevent or treat malaria. When used for prevention it is typically started before potential exposure and continued for several weeks after potential exposure. It can be used to treat mild or moderate malaria but is not recommended for severe malaria. It is taken by mouth.

Key facts

Drug.Verifiedfields
changed
Drug.Watchedfields
changed
Drug.verifiedrevid
458774403
Drug.image
Mefloquine chemical structure.svg
Drug.image_class
skin-invert-image
Drug.width
185px
Drug.tradename
Lariam, Mephaquin, Mefliam, others
Drug.MedlinePlus
a603030
Drug.DailyMedID
Mefloquine
Drug.pregnancy_AU
B3
Drug.routes_of_administration
Oral
Drug.class
Antimalarial
Drug.ATC_prefix
P01
Drug.ATC_suffix
BC02
Drug.legal_AU
S4
Drug.legal_CA
Rx-only
Drug.legal_UK
POM
Drug.legal_US
Rx-only

via Wikipedia infobox

Chemical data

Formula
C17H16F6N2O
Molecular weight
378.31 g/mol
IUPAC name
[2,8-bis(trifluoromethyl)quinolin-4-yl]-piperidin-2-ylmethanol
SMILES
C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O
InChIKey
XEEQGYMUWCZPDN-UHFFFAOYSA-N
XLogP
3.6
Polar surface area
45.2 Ų
H-bond donors
2
H-bond acceptors
9
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Approved
Molecule type
Small molecule
First approval
1989
Admin. routes
oral
Indications
malaria, Plasmodium falciparum malaria, progressive multifocal leukoencephalopathy, urinary schistosomiasis

via ChEMBL · EBI

Research

3,628 papers

via PubMed

Wikidata facts

Mass
378.116682
Has use
medication
Show 8 more facts
Commons category
Mefloquine
chemical formula
C₁₇H₁₆F₆N₂O
significant drug interaction
droperidol
World Health Organisation international non-proprietary name
mefloquine
medical condition treated
malaria
canonical SMILES
C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O
defined daily dose
1
subject has role
malaria prophylaxis
Sources (6)

via Wikidata · CC0

~15 min read

Encyclopedic overview

20 sections
Contents
  • Medical uses
  • Malaria prevention
  • Malaria treatment
  • Resistance to mefloquine
  • Contraindications
  • Pregnancy and breastfeeding
  • Adverse effects
  • Neurologic and psychiatric
  • Cardiac
  • Pharmacology
  • Pharmacodynamics
  • Off-target activities
  • Pharmacokinetics
  • Chemistry
  • History
  • Military
  • Research
  • References
  • Further reading
  • External links

Mefloquine, sold under the brand name Lariam among others, is a medication used to prevent or treat malaria. When used for prevention it is typically started before potential exposure and continued for several weeks after potential exposure. It can be used to treat mild or moderate malaria but is not recommended for severe malaria. It is taken by mouth.

Common side effects include vomiting, diarrhea, headaches, sleep disorders, and a rash. Serious side effects include potentially long-term mental health problems such as depression, hallucinations, and anxiety and neurological side effects such as poor balance, seizures, and ringing in the ears. It is therefore not recommended in people with a history of mental health problems or epilepsy. It appears to be safe during pregnancy and breastfeeding.

Excerpted from Wikipedia’s “mefloquine” article, available under the CC BY-SA 4.0 licence.

Gallery (7)